Immunovant Inc. share price logo

Immunovant Inc.

NASDAQ: IMVT

Mid Cap

$42.60

+1.67

(+4.08%)

as on

Immunovant Inc. Stock Performance

as on August 13, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $40.70
    $42.58
    downward going graph

    4.46%

    Downside

    -0.05%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $14.47
    $42.62
    downward going graph

    66.03%

    Downside

    0.05%

    Upside

    downward going graph

Immunovant Inc. share price movements today

Previous Close
$40.93
Open
$41.17
Volume
1.6M
Day's Low - High
$40.70 - $42.58
52 Week Low - High
$14.47 - $42.62

Immunovant Inc. Historical Returns

1 Month Return
+ 10.08 %
3 Month Return
+ 45.64 %
1 Year Return
+ 168.09 %
3 Year Return
+ 89.59 %
5 Year Return
+ 440.61 %

Immunovant Inc. Stock Fundamentals & Key Indicators

Check Immunovant Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.8B

EPS (TTM)

-2.6083

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-565.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-80.10%

Immunovant Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunovant Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$8.8B440.61%NA0.00%NA
BUY$44.4B704.19%NA0.00%NA
BUY$132.8B172.51%28.935.00%NA
BUY$83.2B27.56%19.4227.87%0.45999999999999996%

Stock Returns calculator for Immunovant Inc. Stock including INR - Dollar returns

The Immunovant Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Immunovant Inc. investment value today

Current value as on today

₹2,91,700

Returns

₹1,91,700

(+191.7%)

Returns from Immunovant Inc. Stock

₹1,68,093 (+168.09%)

Dollar Impact

₹23,606 (+23.61%)

Analyst Recommendation on Immunovant Inc. Stock

Based on 22 analysts

BUY

95.45%

Buy

4.55%

Hold

0.00%

Sell

Based on 22 analysts, 95.45% of analysts recommend a 'BUY' rating for Immunovant Inc.. Average target price of $48.33

Immunovant Inc. Share Price Target

Get share price movements and forecasts by analysts on Immunovant Inc..

What analysts predicted

11.86%UPSIDE

Target Price

$48.33

Current Price

$42.6

Analyzed by

22 Analysts

Target

$48.33

Immunovant Inc. target price $48.33, a slight upside of 11.86% compared to current price of $42.6. According to 22 analysts rating.

Indian Investors' Interest in Immunovant Inc. Stock

Search interest for Immunovant Inc. Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-63% versus previous 30 day period

Immunovant Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
-
-
-
0
-
-
-
-
7
Gross Profit
1
0
0
0
0
0
0
0
-
7
Operating Income
-80
-94
-115
-114
-113
-127
-131
-114
-159
-153
EBITDA
-75
-86
-108
-110
-105
-119
-125
-108
-150
-153
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-75
-87
-109
-110
-105
-119
-125
-109
-150
-153
Income Tax Expense
0
0
0
0
0
0
0
1
-2
-
Net Income
-75
-87
-109
-111
-106
-120
-126
-110
-147
-153
Net Profit Margin
-5021.27%
0.00%
0.00%
0.00%
-66530.63%
0.00%
0.00%
0.00%
0.00%
-2159.61%

Immunovant Inc. Annual Profit & Loss

All numbers in Millions USD

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-1
-1
0
0
0
Operating Income
-59
-108
-156
-208
-270
-438
-532
EBITDA
-65
-108
-156
-198
-258
-412
-504
Interest Expense
0
-
0
12
49
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-66
-107
-156
-210
-258
-412
-505
Income Tax Expense
0
0
0
0
0
0
0
Net Income
-66
-107
-156
-210
-259
-413
-505
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunovant Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-87
-109
-111
-106
-120
-126
-110
-147
-153
Operating Cash Flow
-76
-88
-100
-110
-117
-102
-92
-95
-124
Investing Cash Flow
0
0
0
0
-
-
-
0
-
Financing Cash Flow
0
0
2
450
2
24
564
3
20
Change in Cash
-75
-87
-98
339
-115
-77
472
-92
-104

Immunovant Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
0
-28
-66
-107
-156
-210
-259
-413
-505
Operating Cash Flow
-
-28
-53
-83
-106
-188
-214
-375
-407
Investing Cash Flow
-
0
0
0
0
0
0
0
0
Financing Cash Flow
0
35
146
383
200
70
472
454
595
Change in Cash
0
6
93
299
93
-117
258
78
188

Global Institutional Holdings in Immunovant Inc.

Funds
Holdings
State Street Corp
2.2%
Morgan Stanley - Brokerage Accounts
1.88%
Farallon Capital Management, L.L.C.
0.76%
Vanguard Portfolio Management, LLC
1.8%
Armistice Capital, LLC
1.73%

Insights on Immunovant Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, IMVT stock has moved up by 45.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 469.1% return, outperforming this stock by 301.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 584.4% return, outperforming this stock by 494.8%

About Immunovant Inc.

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
OrganisationImmunovant Inc.
Headquarters1000 Park Forty Plaza, Durham, NC, United States, 27713
IndustryBiotechnology
CEODr. Eric Venker M.D., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Immunovant Inc.

Name

Title

Dr. Eric Venker M.D., Pharm.D.

CEO & Director

Dr. Jay S. Stout M.S., Ph.D.

Chief Technology Officer

Ms. Christine Blodgett

Senior Vice President of Human Resources

Ms. Becky Merlina

Senior VP & Global Head of Quality

Ms. Yan Zheng M.S., Ph.D.

Senior Vice President of Biostatistics, Programming & Data Management

Ms. Sheetal Patel M.B.A., M.D., M.S.

Senior Vice President of Clinical Development

Dr. Frank M. Torti M.B.A., M.D.

Executive Chairperson of the Board

Mr. Tiago M. Girao CPA

Chief Financial Officer

Ms. Melanie Gloria B.S.N.

Chief Operating Officer

Mr. Christopher A. Van Tuyl Esq., J.D.

Chief Legal Officer & Corporate Secretary

FAQs

What is Immunovant Inc. share price today?

Immunovant Inc. share price today is $42.60 as on at the close of the market. Immunovant Inc. share today touched a day high of $42.58 and a low of $40.70.

What is the 52 week high and 52 week low for Immunovant Inc. share?

Immunovant Inc. share touched a 52 week high of $42.62 on and a 52 week low of $14.47 on . Immunovant Inc. stock price today i.e. is closed at $42.60,which is 0.05% down from its 52 week high and 194.40% up from its 52 week low.

What is Immunovant Inc.'s market capitalisation today?

Immunovant Inc. market capitalisation is $0.01T as on .

How to invest in Immunovant Inc. Stock (IMVT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunovant Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunovant Inc. Shares that will get you 0.0352 shares as per Immunovant Inc. share price of $42.60 per share as on August 13, 2026 at 8:45 am IST.

What is the minimum amount required to buy Immunovant Inc. Stock (IMVT) from India?

Indian investors can start investing in Immunovant Inc. (IMVT) shares with as little as ₹95.32 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.20 in Immunovant Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunovant Inc. share’s latest price of $42.60 as on August 13, 2026 at 8:45 am IST, you will get 0.2347 shares of Immunovant Inc.. Learn more about fractional shares .

What are the returns that Immunovant Inc. has given to Indian investors in the last 5 years?

Immunovant Inc. stock has given 440.61% share price returns and 28.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?